commercialize KRYSTEXXA

Related by string. * Commercialize . Commercializes . commercializes : commercializes innovative therapeutics . commercializes innovative biopharmaceuticals . successfully commercialize REOLYSIN . commercializes differentiated products . commercialize microRNA therapeutics / Krystexxa : KRYSTEXXA TM pegloticase . KRYSTEXXA formerly . commercializing KRYSTEXXA ™ . KRYSTEXXA TM * *

Related by context. All words. (Click for frequent words.) 61 looking statements.Such 58 Amedia filings 57 EHSK 57 forward lookinginformation 55 theseforward looking 54 thispress release 54 thisrelease 54 Theseforward looking 54 risks anduncertainties 53 newproducts 53 anyforward looking 53 PD2i ® algorithm 53 ADSI cautions 53 without limitation EMRISE 53 involve risksand uncertainties 53 differ materially fromthose 53 CLX Investments 53 risksand uncertainties 53 MerueloMaddux 53 Immtech clinical trials 52 Forward lookingstatements 52 website www.nyandcompany.com 52 ourability 52 BCII router 52 IP PBX telephony 52 cadence regulatory approvals 52 reflect SpatiaLight 51 statements arebased 51 NYMET Holdings 51 HANA MAX 51 ourbusiness 51 theglobe.com inc 51 looking statements.These 51 regarding Heska 51 differ materiallyfrom 51 Cautionary Statements Certain 51 forwarda ^ looking 51 CAUTIONARY STATEMENT Statements 51 professionals technological obsolescence 51 statementsare 51 eTag assays 51 Thesestatements 51 futureperformance 51 Enpath ability 51 Azedra ™ 51 notlimited 50 events orcircumstances 50 suchstatements 50 DSL.net s 50 ability tosuccessfully 50 theforward looking 50 HealthGate ability 50 explanatory paragraph regarding 50 visit www.c cor.com 50 HartLab 50 Ptek 50 APPY believes 50 successfully integrate Legerity 50 Cautionary Disclosures 50 cause actualresults 50 XSEL beliefs 50 reflect GuestLogix 50 reflect iSIGN Media 50 MultiCell bases 50 XFMedia beliefs 50 LensAR Laser System 50 suchforward looking 50 similarexpressions 49 forward lookingstatement 49 Suchforward looking 49 futureresults 49 VeraTag assays 49 theability 49 barrenwort extraction efficiency 49 including withoutlimitation 49 TomoTherapy judgments 49 Agria beliefs 49 Spot Relevance 49 reflect Ronn Motors 49 anduncertainties 49 reflect Medicago 49 SpectraScience actual 49 reflect Ronn Motor 49 involve risks anduncertainties 49 statementsregarding 49 impair Lillian Vernon 49 Assumptions underlying 49 SAFE HARBOR Certain 49 LOT NUMBER DESCRIPTION 49 iii Cubist 49 ProUroCare 49 CAUTIONARY STATEMENT Estimates 49 theperformance 49 eCOST 49 See www.noven.com 49 MicroTel 49 XSell platform 49 EVEP undertakes 49 These statementsare 49 without limitation Terremark 48 FSRU conversions 48 offerings visit www.balqon.com 48 Andrea Zopp Exelon 48 commercializing ArteFill 48 BioGold Fuels 48 historical facts areforward 48 Wikifamilies 48 EMPOWER pivotal trial 48 concerning Epigenomics AG 48 OrCrude TM process 48 Axia Group 48 LandStar Inc. s 48 ESET Remote Administrator 48 maydiffer materially 48 delivery platforms SDPs 48 factors thatcould 48 ResultsOnDemand 48 Celacade TM System 48 www.rona.ca. 48 companyaEUR TM s 48 viii inability 48 Targacept cautions 48 Mediaseed R 48 OmniComm intends 48 Crisa acquisition 48 â € œwill â 48 Pervasip actual 48 reflecting Maximizer Software 48 otherrisks 48 Shire plc Attention Deficit 48 OfficeScreen 48 Zemiva TM Trofex TM 48 ETHEX Customer Service 48 LogicVision disclaims 48 www.moduslink.com 48 forward.looking statements 48 deploy MDCE services 47 Azedra TM Onalta TM 47 Stephen Ghiglieri Chief 47 GoSolutions 47 CompAir acquisition 47 Redishred 47 CCG TH# 47 looking statements includingbut 47 theinformation 47 PPG Industries periodic 47 PLAYLOGIC 47 involverisks 47 TSX POU Paramount 47 TM SH AWD 47 differmaterially 47 visit www.trellia.com 47 historicalfacts 47 · Demonstrated 47 SearchHelp communications 47 Harmonic Electra 47 abilityto 47 XL# XL# XL# XL# 47 Beralcast Corporation 47 nothistorical facts 47 intents beliefs 47 TTGL 47 ourproducts 47 gstec@ap.org 47 diodes-fin@diodes.com 47 Insulet inability 47 PGxPredict tests 47 Crestwood LP 47 StratoComm Corporation 47 Veri Tek 47 financialperformance 47 AutoloGel tm System 47 VIOXX Lawsuits 47 Rexahn licensees 47 commercialize ZYFLO CR 47 vii Cubist ability 47 cystic fibrosis bronchiectasis pulmonary 47 www.titanpharm.com 47 VAALCO stockholders 47 rxRNA ™ compounds 47 TranSwitch indebtedness 47 Definitive Proxy 47 ir@agfeedinc.com 47 incorporating FalconStor 47 couldcause actual results 47 products visit www.adm.com 47 Exelbine 47 results todiffer materially 47 TechFaith beliefs 47 within themeaning 46 FDA Complete Response 46 oral NSAIDs 46 Caneum 46 RXi Pharmaceutical Corporation 46 novel therapeutic modality 46 Sinovac beliefs 46 EMM suite 46 market fluctuations investee 46 Statement Statements 46 actualresults 46 FirstPass Silicon Characterization Lab 46 Alnylam #x# 46 constituteforward looking 46 HDF therapy 46 Allovectin 7 r 46 Lipid Sciences assumes 46 website www.corriente.com 46 performanceand 46 PGP Acquisition 46 iii Immtech ability 46 Theforward looking 46 eLinear Annual Report 46 TRUSTCASH 46 areforward looking 46 personnal information 46 Brascan SoundVest Funds 46 DXL TM antibodies 46 representations warranties covenants 46 AuGRID Corporation 46 CompanyaEUR TM s 46 Zemiva ™ 46 Lasertel subsidiary 46 Pashminadepot.com 46 synergies therefrom 46 Complete Response 46 risksassociated 46 lorcaserin NDA 46 savings KayCee persuaded 46 PBIH 46 FalconStor OEM 46 hands busily gesticulating 46 Cellceutix actual 46 Sify undertakes 46 HBMPSLD 46 TriPath Oncology 46 Eutronsec 46 Chemed communications 46 Mago ® 46 TCG Opal specification 46 AusAm 46 Neo Kidney Augment 46 Nexia Holdings 46 financialstatements 46 Vertical Networks 46 ValueSetters 46 commercialize BiDil 46 enTourage eDGe Facebook 46 Publication Classified Ad 46 please email info@sinovac.com 46 Amedia assumes 46 assorted liquid coolants 46 withrespect 46 guarantees offuture performance 46 Atheros disclaims 46 looking statementsare 46 factorsthat 46 Vion Annual Report 46 Komunik 46 ADSI reliance 45 Financing Condition 45 timetable Dresslar 45 reflect Sentry Select 45 vii IBC 45 looking statements.Forward 45 Varian Semiconductor dependence 45 successfully commercialize Iluvien 45 Complete Response Letter 45 couldcause 45 Unpublished letters 45 treat GI GVHD 45 todiffer materially 45 Fischer Zoth 45 forwardlooking statements 45 Hiru Corporation cautions 45 TrueKnowledge Platform TM 45 Aspyra actual 45 Macrovision assumes 45 Intellon ICs 45 ourcustomers 45 Filtran Microcircuits Inc. 45 InterDigital differentiated technology 45 EMD Storage 45 BLVT BulovaTech 45 Pixelplus cautions readers 45 FFDOs must 45 expressed orimplied 45 ii Nephros 45 Jerry Cutini 45 Lightning EFDs 45 tosuccessfully 45 ZipGlobal 45 WWD.com subscribers 45 expressly qualifies 45 itsproducts 45 Nektar proprietary 45 acquisitions divestitures joint ventures 45 ii Immtech ability 45 solutionsthat 45 currentexpectations 45 Biogold Fuels 45 affecting IsoTis 45 OTI Annual Report 45 causeactual results 45 CoreStream 45 Magma undertakes 45 concerning Intercell AG 45 SIMOX SOI 45 proprietary Capillary Aerosolization Technology 45 Rexahn actual 45 programs visit http:/www.dendreon.com/ 45 BioSante licensees 45 QoS metrics 45 please visit www.advantex.com 45 Patrick Stakenas 45 APNB believes 45 AMWO 45 FL# recipients 45 PARSEC TM System 45 TOCOSOL Paclitaxel 45 Surfaxin LS 45 regarding AngelCiti 45 Excellent interpersonal skills 45 requestor petitioner 45 projections anticipations 45 Linkcon 45 HEPLISAV ™ 45 BancTec intentions 45 Versata Enterprises 45 operational efficiencies FETCH 45 Defibtech AED 45 nonoccurrence 45 Ontus 45 Refinancing Transactions 45 Dyax phage display 45 website AARP.org 45 minimally dilutive 45 CommVault beliefs 45 PV module efficiencies 45 InfoStrength SES 45 Company website www.jcrew.com 45 ImmuneRegen undertakes 45 iv IBC 45 CEO Magnus Ryde 45 aEURoeforward looking 45 vii Dynamic 45 Inc. Karen VanDerBosch 44 businesstravel division 44 Biophan anticipates 44 dyed yak hair 44 Dimension BST 44 patented BEMA 44 MedCom USA Inc. 44 looking statementsâ € 44 Lyron Bentovim 44 update anyforward looking 44 please email chris@chfir.com 44 respecting DST 44 GINSMS 44 Moventis 44 IntelGenx assumes 44 uncertainties thatcould cause 44 results ofoperations 44 George Migausky Executive 44 contained inthis 44 Forwardlooking statements 44 InCard 44 LibiGel ® testosterone gel 44 x Immtech 44 orimplied 44 SCP Standards quantify 44 http:/www.camtek.co.il 44 XFMedia filings 44 software visit http:/www.borland.com 44 Cobalamin TM mediated 44 Addex Pharmaceuticals Ltd 44 regarding allosteric modulators 44 Immtech scientists 44 Mr. Silvasan 44 Severe hypersensitivity reactions 44 Poly ICLC 44 mergers dispositions 44 software MeetingLinc LearnLinc 44 actionability 44 Kip Hallman 44 explanatory paragraph expressing 44 SumTotal Systems filings 44 Zanaflex tablets 44 specialty silicone elastomer 44 CombinatoRx Neuromed 44 ESPRE Solutions Inc. 44 Thinkpath 44 CORLUX CORT # 44 ADAM disclaims 44 opioid tolerance 44 itsbusiness 44 smears forcefully 44 Somaxon ability 44 Jupitermedia dependence 44 PVR lessees 44 avoiding extinction Sallinger 44 ADVENTRX 44 AIF identifies 44 technological innovations adversely affecting 44 Auxilium assessments 44 NetScout logo 44 Comdial Corporation 44 Current Merger Agreement 44 please visit http:/www.weingarten.com 44 HigherEd Analytics 44 ServerEngines Corporation 44 dispositions joint ventures 44 Nortel Networks strategic alliances 44 PR NEWSWIRE copy 44 Dolby Axon 44 Excess Cash Flow 44 MethyPatch 44 deems immaterial 44 SumTotal deploys mission 44 This exemplifies SYSPRO 44 refinance indebtedness 44 evaluating Questcor 44 Eat Drink Snack 44 Bernard Ducat 44 CellPort Technologies 44 Wavefront expressly disclaims 44 GigaMedia cautions readers 44 M3O 44 DataWorld 44 KRYSTEXXA TM 43 productsand services 43 Newtek beliefs 43 results performance orachievements 43 risks associated therewith 43 beidentified 43 looking statementswithin 43 Nuinsco believes 43 Strong interpersonal skills 43 MassARRAY platform 43 GrowthWorks refers 43 bookmark passages 43 market PolyHeme commercially 43 reflect DTRO 43 relocation visit www.ohiomeansbusiness.com 43 anticipations estimates 43 thedate hereof 43 toupdate 43 Nellix technology 43 Technoprises 43 Housewares Segment 43 IMGRC 43 D. Medicals 43 Plastic2Oil sites 43 describe CoBiz 43 visit www.parpharm.com 43 adversely affect Hologic 43 DATES Written comments 43 NETg acquisition 43 explanatory paragraph 43 PharPoint 43 BioForce Nanosciences actual 43 NumeriTrack 43 WiMetry platform 43 Behavioral Analytics TM 43 Francois Legros 43 Shortfall Application Form 43 Nortel strategic alliances 43 RR Donnelley periodic filings 43 HIMC Corporation 43 patented Bioral R nanocochleate 43 patented Bioral cochleate technology 43 PDTI 43 LibiGel NDA 43 Pure Biofuels ability 43 Translation Workspace 43 * Potentially libelous 43 AGCO disclaims 43 Override Agreement 43 Kensington Leasing 43 Walter Geldenhuys 43 content@pinr.com 43 MCOT TM 43 Therapeutic Antibodies segment 43 MTM Technologies disclaims 43 PD2i Analyzer ™ 43 Luminex Reports 43 NSDS III 43 EnterpriseTenFold SOA 43 Irdeto CAS 3 43 Hardware Solutions Competency 43 GenVec cautions 43 Generx TM 43 d SIGA 43 Statements Certain 43 MNDL 43 Medicago disclaims 43 maycause actual results 43 APTIMA HPV assay 43 CSLR expectations regarding 43 forward lookingstatements 43 EGRIFTA ™ 43 timing rescheduling 43 gastroenterologists endocrinologists 43 Symphony tCGM 43 integrate restructurings consolidations 43 Portfolio.com offerings 43 Joe Bergera 43 proprietary LNA 43 SANnet 43 lower quinidine dose 43 epigenetic therapeutics 43 Candela periodic 43 IsoTis stockholders 43 proprietary capillary aerosolization 43 reflect VIQ Solutions 43 NexPrise 43 consents authorizations 43 filingswith 43 andassumptions 43 Resverlogix Corp. 43 business@scni.com 43 Equant assumes 43 NitroMed BiDil 43 H. Francis Fytton 43 ELEVESS 43 theCompany 43 i2 expressly disclaims 43 develop electroporation 43 Option IVC Filter 43 fully substitutable generic 43 conflicting inferences 43 Intermezzo ® NDA 43 eTelecare assumes 43 XP# XP# 43 distort comparability 43 Herley Industries Inc 43 reflect events orcircumstances 43 Cytogen periodic filings 43 Alexandrite laser technology 43 concerning Wowjoint 43 e mail lifestyle@readingeagle.com 42 PRECISE trial 42 assumes noobligation 42 TRIOLEX HE# APOPTONE HE# 42 Medafor shareholders 42 negatives thereof variations thereon 42 limitedto 42 Diomed disclaims 42 withinthe meaning 42 visit www.mmrglobal.com 42 Metretek Florida 42 ECI 1Net framework 42 Healthvision acquisition 42 objectives anticipations 42 Tenaska affiliates 42 CRHI 42 reflect HRTE 42 interWAVE 42 uncertaintiesthat 42 SumTotal stockholders 42 developments affecting SIAF 42 microsurgical disciplines 42 capture exosomes 42 -Amos Harel Haaretz Correspondent 42 PD2i Cardiac Analyzer 42 www.weingarten.com 42 Cheniere Partners 42 eMax Worldwide 42 Physician referral 42 Airesurf 42 withoutlimitation 42 VRDP 42 Plan Disclosure Document 42 Proxy Statements 42 Bioenvision dependence 42 Orosi Mill project 42 Airvana anticipates 42 NKF Electronics 42 without limitation Newlook 42 lender consents 42 Limited NNL 42 targeting Inflammatory Bowel 42 Company noncontributory defined 42 Offerors Commercial applies 42 Carrier Ethernet www.soapstonenetworks.com 42 preceding paragraphs 42 patented digital watermarking 42 via Ipswitch IMail 42 planningIT 42 HemoStase 42 eyeonics inc 42 Gold Reserve Equityholders 42 Techs ceased 42 GuardedNet 42 MTI MTI Micro 42 Clarix 42 Reasonable accommodations 42 SumTotal logo 42 visit www.tpna.com 42 SimEnterprise 42 transmit high-power/high-frequency microwave 42 theavailability 42 Shire Attention Deficit 42 Claude@upi.com 42 OctoPlus NV 42 Dr. Ash Rofail 42 VeraTag technology 42 DMEPOS supplier 42 MobileMe Sync 42 InfoVista proven 42 Prelude SkinPrep Systems 42 OTCS undertakes 42 concerning Alnylam 42 toachieve 42 Bionutrics 42 mStage 42 Kevin Buchi 42 ARPS redemptions 42 hereunder shall 42 Nanobac Pharmaceuticals Inc. 42 VISaer 42 thoseexpressed 42 Sepracor licensees 42 ICT GROUP 42 Decoding Financial 42 Nektar pulmonary 42 TrueInformation 42 www.qustream.com 42 Observation Checklist 42 femtocell ecosystem 42 cranes Fuchs 42 Orthodyne 42 EPIX Pharmaceuticals 42 odds Lutkus 42 Boxed Warning 42 Thinkfilm Before 42 visit www.quadramed.com 42 plastic photochromic lens 42 Gillispie inherits 42 MobiControl 42 CAUTIONARY STATEMENT Certain 42 OptiCon R4 42 Value Creation Plan 42 WesternOne Equity seeks 42 Hemolung 42 uncertainties materialize Shire plc 42 accompanying Explanatory Memorandum 42 toreflect 42 Safe Harbor Forward Looking 42 Jim Nevelle CEO 42 USAISR 42 phrases denoting 42 PBG undertakes 42 please visit www.PositiveIDCorp.com 42 Click Reply 42 performance indicator KPI 42 Dyna Torque 42 visit www.targanta.com 42 professional licensures 42 Group Motorise International 42 Banks.com s 42 GoFish periodic filings 42 #.These statements 42 vaginal lidocaine 42 R Digirad Imaging 42 Heli Electronics Corp 42 SYMLIN 41 DPX Survivac 41 BusinessPartners 41 Infor ERP XA 41 podcast@basf.com 41 please visit www.mscsoftware.com 41 Behavioral Analytics 41 Cautionary Statements section 41 please visit www.cpexpharm.com 41 Timmins Mine Thunder 41 Mr Sidibé 41 MET amplification 41 attorney WH Newbold 41 looking statementsaEUR describe 41 toimplement 41 Nitram Energy 41 Repurchase Notice 41 bestpractices 41 Medify Solutions Limited 41 Anthracite assumes 41 raw materials subassemblies 41 Terumo CVS 41 comply therewith 41 ExamWorks 41 OR INFORMATION INVOLVE 41 ii GTx may 41 adopting SFAS #R 41 Autism impairs 41 affecting ChinaNet 41 commercialize becocalcidiol patented 41 proprietary Vitoss TM 41 Petrowest 41 schedules hereto 41 ArctiCore 41 mPhase Smart NanoBattery 41 visit http:/www.parpharm.com/ 41 Leap RevChain 41 HydroFix ™ 41 heather@chfir.com 41 executional excellence 41 meaningof 41 GENASIS trial 41 Neurobionix 41 clientsâ € ™ 41 ePAK 41 DataFlux enables 41 RDEA# RDEA# RDEA# RDEA# 41 TrueTheater 3D 41 may diverge numerically 41 visit www.oce.com 41 George Migausky 41 EAU Eldorado 41 Penetrating Therapeutics ™ 41 PlanVista 41 owned Cooled ThermoTherapy 41 OnForce marketplace 41 Aventine disclaims 41 concerning InfoSonics 41 affect Zygo Corporation 41 rPA vaccine candidate 41 unattended Scullion 41 Avivo Corporation 41 affect theglobe.com 41 nonelectric businesses 41 WFWS undertakes 41 inter civilizational dialogue 41 Metastorm Enterprise 41 NurOwn TM 41 PREVU i 41 Salisburypost.com 41 PharMerica LTC Transaction 41 Sonic Roxio R 41 Geac intentions 41 Vince Sorace President 41 metric signaling 41 Xencor XmAb 41 affect Pennichuck Corporation 41 PGiSend 41 willy nilly Toner 41 visit www.clicksoftware.com 41 XplosiveStocks.com undertakes 41 nonclinical studies 41 Omtool periodic reports 41 Platform Equinix 41 FREE InvestorXchange.com newsletter 41 Candente relies upon 41 Oncolin Quarterly Reports 41 regardingthe 41 vintner Baron 41 Scivanta 41 Jopari significantly 41 Shenick diversifEye 41 Thalomid R 41 exhibits thereto 41 involve anumber 41 Complete Response letter 41 date hereof disclaim 41 Renovis cautions investors 41 Vyyo assumes 41 free E Newsletters 41 please visit www.vipernetworks.com 41 thePrivate Securities Litigation Reform 41 Anviron undertakes 41 Prospectuses contain 41 DCMO 41 Dr. Tsengas 41 integrates predictive analytics 41 visit www.ucn.net 41 nonqualified retirement 41 Qualitest accelerates 41 AmeriSource 41 FSC certified cardstock 41 disasters McLear 41 Egoli Shaw Stockbroking 41 Current negative coggins 41 toktok 41 information visit www.parpharm.com 41 · Ability 41 GELV gasification technology 41 PalWeb 41 ASA Thinfilm 41 e# periodic 41 KIT VX platform 41 Regains NASDAQ 41 CLIRS trial 41 Linjeta TM 41 WindsorTech 41 Switchless SAN 41 services visit www.sumtotalsystems.com 41 Oncore TM 41 See www.claymore.com CEF 41 visit www.ethosfr.com 41 Z5 Technologies 41 Overall Viability 41 KRYSTEXXA ™ 41 ReCyte 41 Shopping Cart button 41 Ikanos Communications undertake 41 FloTHERM IC 41 MiniBOSS TM 40 PC OEMS 40 Gennum logo 40 clinical endpoints 40 BestBuy.ca Future Shop FutureShop.ca 40 Cobalamin TM 40 Performance Blueprints 40 Optium Corporation 40 Individualize dosing 40 iMergent StoresOnline 40 PIX# trial 40 Spiriva HandiHaler 40 Fab2 capacity 40 Reputable charities 40 HeliScope Sequencer 40 WWD Subscription 40 move stops interday 40 reproduce modify 40 HD DVD playback 40 Qualstar filings 40 www.nac tsx.com 40 render SavWatt products 40 HTTD 40 Jason Cutbirth 40 website www.bancroftfund.com 40 Dolby Contrast 40 disrupting dismantling 40 United AutoWorkers Union 40 GEHC 40 Synvista 40 pediatrician Mensur 40 Citel plc 40 Evolving Systems Tertio 40 TSX VENTURE VV 40 #L Ozone Sterilizer 40 LocatePLUS Statements 40 Christine Lacoste Bordelon 40 Ancept 40 regarding Hyperdynamics Corporation 40 Mr. Owusu Akyaw 40 Tranzeo logo 40 affect Petroflow 40 statementscontained 40 Proposed Transactions 40 Exocrine Pancreatic Insufficiency 40 contingent guaranties 40 adapt AVANT vectoring 40 Application Delivery Networks 40 XYNTHA 40 OraSure Technologies undertakes 40 Long Term Incentive Program 40 concerning AudioCodes 40 Statements - 40 thedate 40 WealthCraft 40 Songwriter Phoebe Snow 40 arenot limited 40 EcaFlo ® 40 Tucows filings 40 services visit www.aspyra.com 40 EXALGO 40 Bobby Yazdani Chairman 40 Sonic Roxio ® 40 Synthetic Fuel segment 40 commercialize DAVANAT ® 40 CAUTIONARY NOTE 40 APNB 40 Telenetics 40 BY MAKING THESE 40 pixantrone NDA 40 distinguishing MDCE products 40 update theseforward looking 40 Cautionary Statement Certain 40 Sepracor anticipates 40 Nastel Technologies 40 Orckit assumes 40 orotherwise 40 Frank Corsaro Brundibar 40 affecting Amarin 40 ALCHEMx Production Platforms 40 IG Markets Limited 40 unrushed methodical manner 40 website GreenGainers 40 Bell Microproducts ISO #:# 40 Stockpoint.com delivers broad 40 unnecessary ventricular pacing 40 undertake noobligation 40 Alchemix chemotherapeutic agent 40 Rosetta Inpharmatics technologies 40 statements ofhistorical fact 40 Corporation EasyLink NasdaqCM 40 newinformation 40 EvaMist NDA submission 40 IFTH Acquisition Corp. 40 #.Forward looking 40 risks associatedwith 40 R Custom NX 40 website www.gladiatorstocks.com 40 Replete electrolytes 40 Semiformal attire 40 PROMÉRICA BANK 40 Chris Dupont P.Eng 40 NewMarket Technology Greenfield 40 Monotype Imaging combines 40 Schedule #N 40 engineered endonuclease technology 40 Novavax cautions 40 Iusacell Celular 40 visit http:/www.ucn.net 40 Automated Benefits Inc. 40 loan origination volumes 40 GHN Agrispan 40 R Witness Actionable 40 Amylin disclaims 40 TradeWorks Marketing 40 Gramercy Realty Loans 40 Cornerstone BioPharma Holdings 40 preserving Iturbi legacy 40 succeed Zamost 40 Arthur Mesher CEO 40 specific dataplane 40 topical hemostat 40 PLIVA acquisition 40 thatmay 40 forwardlooking 40 CAUTIONARY STATEMENTS 40 SHOULD BE READ 40 Tony Tomae Deltacom 40 Pharsight WinNonlin 40 revise anyforward looking 40 label Cosmetic Laser 40 Entology 40 SupportSoft assumes 40 successfully commercialize 40 Wiederseim Associates 40 ISKAN 40 Bill Forbes Pharm.D 40 Hateful racist 40 futureevents 40 concerning Numerex 40 otherfactors 40 trading symbol GCKO 40 GeckoScheduler ™ 40 Interim Filings 40 Chordiant logo 40 ICOS WI 40 Chase Kishner 40 Aspirin ibuprofen acetaminophen 40 financialresults 40 #-hour/#-day cycle 40 Recommendation Statement 40 exemplifies SYSPRO ongoing 40 CAN GENERALLY BE IDENTIFIED 40 SHRIMP Come eat 40 visit www.h2oinnovation.com 40 Ignition Point 40 Nasdaq CHRD 40 concerning Ceragon 40 WCHBlog 40 ZapMyTV 40 Linktone filings 40 WWD.com Archive subscribers 40 Amarin Neuroscience Limited 40 Nephros Annual Report 40 feedback@financialwire.net 40 Abdul Mamah 40 realistic Josehart 40 ILOG SA 40 acquisitions divestitures strategic alliances 40 See http:/www.cepheid.com 40 CoTherix logo 40 areas Fertility Transplantation 40 Corporation OTCBB SVUL 39 Rave Accredited Plus 39 TSCTP 39 One hiccup Soulia 39 thetransaction 39 Realization Strategy 39 earnout payments 39 Nutrient deficiencies 39 Therapeutic Diagnostics 39 uncertainties 39 varietyof 39 predictively 39 work stoppages slowdowns 39 C2 GLOBAL TECHNOLOGIES 39 Internap FCP 39 prequalification questionnaire 39 CacheFlow appliance 39 quantifiable metrics 39 Domilens 39 La.Code Crim.P. art 39 dimesylate Attention Deficit 39 SAFE HARBOUR 39 Whitebox Filers

Back to home page